Published in Ann Allergy Asthma Immunol on November 01, 2002
Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol Pract (2014) 1.45
Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res (2010) 1.19
Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2013) 0.96
Factors driving the aspirin exacerbated respiratory disease phenotype. Am J Rhinol Allergy (2015) 0.93
Epidemiology and differential diagnosis of nasal polyps. Am J Rhinol Allergy (2013) 0.90
Chronic rhinosinusitis and antibiotics: the good, the bad, and the ugly. Am J Rhinol Allergy (2013) 0.88
Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease. J Immunol (2014) 0.87
ICON: chronic rhinosinusitis. World Allergy Organ J (2014) 0.86
Differential gene expression profile in PBMCs from subjects with AERD and ATA: a gene marker for AERD. Mol Genet Genomics (2012) 0.83
Interleukin-4 in the Generation of the AERD Phenotype: Implications for Molecular Mechanisms Driving Therapeutic Benefit of Aspirin Desensitization. J Allergy (Cairo) (2012) 0.82
Rhinosinusitis and aspirin-exacerbated respiratory disease. J Allergy (Cairo) (2012) 0.80
Aspirin-exacerbated asthma. Allergy Asthma Clin Immunol (2008) 0.79
Aspirin sensitivity and chronic rhinosinusitis with polyps: a fatal combination. J Allergy (Cairo) (2012) 0.79
Symptom-Based Clustering in Chronic Rhinosinusitis Relates to History of Aspirin Sensitivity and Postsurgical Outcomes. J Allergy Clin Immunol Pract (2015) 0.78
Aspirin-sensitive asthma and upper airway diseases. Am J Rhinol Allergy (2012) 0.78
Immunomodulatory treatments for aspirin exacerbated respiratory disease. Am J Rhinol Allergy (2012) 0.77
Exonic variants associated with development of aspirin exacerbated respiratory diseases. PLoS One (2014) 0.76
Mite-induced inflammation: More than allergy. Allergy Rhinol (Providence) (2012) 0.76
The IL1B-511 Polymorphism (rs16944 AA Genotype) Is Increased in Aspirin-Exacerbated Respiratory Disease in Mexican Population. J Allergy (Cairo) (2011) 0.76
Automated identification of an aspirin-exacerbated respiratory disease cohort. J Allergy Clin Immunol (2016) 0.75
Nasal polyps in patients with asthma: prevalence, impact, and management challenges. J Asthma Allergy (2016) 0.75
The whole - genome expression analysis of peripheral blood mononuclear cells from aspirin sensitive asthmatics versus aspirin tolerant patients and healthy donors after in vitro aspirin challenge. Respir Res (2015) 0.75
Hypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis. Curr Allergy Asthma Rep (2015) 0.75
Aspirin Intolerance: Experimental Models for Bed-to-Bench. Curr Drug Targets (2016) 0.75
Epidemiology of chronic rhinosinusitis, selected risk factors, comorbidities, and economic burden. GMS Curr Top Otorhinolaryngol Head Neck Surg (2015) 0.75
Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis. Immunol Allergy Clin North Am (2016) 0.75
Chronic Rhinosinusitis with Nasal Polyps. J Allergy Clin Immunol Pract (2016) 0.75
Aspirin-exacerbated respiratory disease: Prevalence, diagnosis, treatment, and considerations for the future. Am J Rhinol Allergy (2016) 0.75
Galectin-10 is released in the nasal lavage fluid of patients with aspirin-sensitive respiratory disease. ScientificWorldJournal (2012) 0.75
Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease. Immunol Allergy Clin North Am (2016) 0.75
Update on the Management of Aspirin-Exacerbated Respiratory Disease. Allergy Asthma Immunol Res (2016) 0.75
Pharmacogenomics of off-target adverse drug reactions. Br J Clin Pharmacol (2017) 0.75
Association of TRPM3 Polymorphism (rs10780946) and Aspirin-Exacerbated Respiratory Disease (AERD). Lung (2016) 0.75
Aspirin-exacerbated respiratory disease and current treatment modalities. Eur Arch Otorhinolaryngol (2016) 0.75
Alcohol and the Lung. Alcohol Res (2017) 0.75
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol (2010) 5.55
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol (2010) 2.98
Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol (2003) 2.26
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med (2002) 1.90
Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol (2007) 1.77
The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2005) 1.69
Food allergy: a practice parameter update-2014. J Allergy Clin Immunol (2014) 1.60
Excess dampness and mold growth in homes: an evidence-based review of the aeroirritant effect and its potential causes. Allergy Asthma Proc (2007) 1.51
Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res (2010) 1.19
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. Nutr Res (2011) 1.14
Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2003) 1.12
The safety of celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum (2002) 1.09
Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2006) 1.00
The united allergic airway: connections between allergic rhinitis, asthma, and chronic sinusitis. Am J Rhinol Allergy (2012) 0.98
Aspirin sensitivity: implications for patients with coronary artery disease. JAMA (2004) 0.97
Effect of leukotriene modifier drugs on the safety of oral aspirin challenges. Ann Allergy Asthma Immunol (2006) 0.96
Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis. Ann Allergy Asthma Immunol (2008) 0.95
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report. Nutrition (2011) 0.92
Selection of patients for aspirin desensitization treatment. J Allergy Clin Immunol (2006) 0.90
Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2003) 0.87
Sensitivity to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol (2002) 0.86
Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2010) 0.86
Aspirin-exacerbated respiratory disease: burden of disease. Allergy Asthma Proc (2012) 0.85
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel report. J Am Acad Dermatol (2011) 0.85
Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2008) 0.85
An epidemic of over diagnosing drug allergies. Allergy Asthma Proc (2014) 0.83
Clopidogrel desensitization after drug-eluting stent placement. J Am Coll Cardiol (2007) 0.83
The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges. J Allergy Clin Immunol (2007) 0.83
The clinical dilemma of "silent desensitization" in aspirin-exacerbated respiratory disease. Allergy Asthma Proc (2013) 0.82
Aspirin-exacerbated respiratory disease: update on pathogenesis and desensitization. Semin Respir Crit Care Med (2012) 0.81
Failure to maintain an aspirin-desensitized state in a patient with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2006) 0.79
Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2004) 0.78
Cardiovascular prophylaxis and aspirin "allergy". Immunol Allergy Clin North Am (2012) 0.78
Does it make sense to "desens"? Aspirin desensitization in the treatment of chronic rhinosinusitis. Curr Allergy Asthma Rep (2006) 0.78
Classification of reactions to nonsteroidal antiinflammatory drugs. Immunol Allergy Clin North Am (2012) 0.77
The Difficult-to-Control Asthmatic: A Systematic Approach. Allergy Asthma Clin Immunol (2006) 0.77
Supraesophageal reflux disease: a review of the literature. Allergy Asthma Proc (2014) 0.77
Aspirin desensitization in aspirin-exacerbated respiratory disease. Immunol Allergy Clin North Am (2012) 0.77
Making the call: the diagnosis of acute community-acquired bacterial sinusitis. Am J Rhinol (2006) 0.77
Does suppression of IL-4 synthesis by aspirin explain the therapeutic benefit of aspirin desensitization treatment? J Allergy Clin Immunol (2010) 0.77
Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2011) 0.76
Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2005) 0.76
Aspirin as a cause of pancreatitis in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2012) 0.76
Side effects from daily aspirin treatment in patients with AERD: Identification and management. Allergy Asthma Proc (2011) 0.75
Aspirin-exacerbated respiratory disease: is it in our DNA? Ann Allergy Asthma Immunol (2011) 0.75
Cross-reactivity of cyclooxygenase 2 inhibitors in patients with a history of cutaneous reactions to cyclooxygenase 1 inhibitors. Ann Allergy Asthma Immunol (2005) 0.75
Evidence-based protocols for oral NSAID challenges. J Pediatr (2006) 0.75
Hydroxyurea in the treatment of Churg-Strauss syndrome. J Allergy Clin Immunol (2009) 0.75
Approach to patients with aspirin hypersensitivity and acute cardiovascular emergencies. Allergy Asthma Proc (2013) 0.75
Nonsteroidal anti-inflammatory drug-induced reactions and desensitization. J Asthma (2004) 0.75
Macrolide antibiotics as anti-inflammatory agents. Curr Allergy Asthma Rep (2005) 0.75
Sinusitis and chronic progressive exercise-induced cough and dyspnea. Allergy Asthma Proc (2009) 0.75
Assessment of sensitization risk of a laundry pre-spotter containing protease. Cutan Ocul Toxicol (2011) 0.75
Characterization of aspirin allergies in patients with coronary artery disease. Ann Allergy Asthma Immunol (2013) 0.75
Role of aspirin and other nonsteroidal anti-inflammatory drugs in aspirin-exacerbated respiratory disease. Expert Rev Clin Immunol (2006) 0.75
Methicillin-resistant Staphylococcus aureus pelvic abscesses in a female after gynecologic pelvic surgery. Am J Obstet Gynecol (2011) 0.75